Christian J. Taverna

Munsterlingen, TG, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Updated recommendations for diagnosis and treatment of multiple myeloma in Switzerland.

Updated recommendations for diagnosis and treatment of multiple myeloma in Switzerland.

Journal: Swiss medical weekly

Published: October 23, 2025

Pertuzumab as second‑ or later‑line therapy for human epidermal growth factor receptor 2‑positive metastatic breast cancer: A clinical experience.

Pertuzumab as second‑ or later‑line therapy for human epidermal growth factor receptor 2‑positive metastatic breast cancer: A clinical experience.

Journal: Molecular and clinical oncology

Published: December 29, 2022

Decision-Making among Experts in Advanced Hodgkin Lymphoma.

Decision-Making among Experts in Advanced Hodgkin Lymphoma.

Journal: Oncology

Published: May 12, 2022

Unusual Cause of Acute Kidney Failure in a Patient with Metastatic Bladder Carcinoma Undergoing Palliative Chemotherapy

Unusual Cause of Acute Kidney Failure in a Patient with Metastatic Bladder Carcinoma Undergoing Palliative Chemotherapy

Journal: Praxis

Published: October 14, 2020

Prolonged rituximab maintenance in follicular lymphoma patients: long-term results of the SAKK 35/03 randomized trial.

Prolonged rituximab maintenance in follicular lymphoma patients: long-term results of the SAKK 35/03 randomized trial.

Journal: Blood advances

Published: July 06, 2020

Spontaneous Tumor Lysis Syndrome.

Spontaneous Tumor Lysis Syndrome.

Journal: Case reports in oncology

Published: June 19, 2020

Prognostic value of POD24 validation in follicular lymphoma patients initially treated with chemotherapy-free regimens in a pooled analysis of three randomized trials of the Swiss Group for Clinical Cancer Research (SAKK).

Prognostic value of POD24 validation in follicular lymphoma patients initially treated with chemotherapy-free regimens in a pooled analysis of three randomized trials of the Swiss Group for Clinical Cancer Research (SAKK).

Journal: British journal of haematology

Published: May 04, 2020

Updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland.

Updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland.

Journal: Swiss medical weekly

Published: April 04, 2019

Diagnosis and treatment of follicular lymphoma: an update.

Diagnosis and treatment of follicular lymphoma: an update.

Journal: Swiss medical weekly

Published: July 26, 2018

Neisseria elongata infection associated with complement inhibition during treatment of paroxysmal nocturnal haemoglobinuria.

Neisseria elongata infection associated with complement inhibition during treatment of paroxysmal nocturnal haemoglobinuria.

Journal: British journal of haematology

Published: April 21, 2018

Supplementum 216: Diagnosis and treatment of marginal zone lymphoma.

Supplementum 216: Diagnosis and treatment of marginal zone lymphoma.

Journal: Swiss medical weekly

Published: August 09, 2016

Bendamustine, lenalidomide and dexamethasone (BRd) has high activity as 2nd -line therapy for relapsed and refractory multiple myeloma - a phase II trial.

Bendamustine, lenalidomide and dexamethasone (BRd) has high activity as 2nd -line therapy for relapsed and refractory multiple myeloma - a phase II trial.

Journal: British journal of haematology

Published: August 01, 2016

Showing 1-12 of 21

Last Updated: 09/26/2026